HONG KONG – Boehringer Ingelheim GmbH will add to its lung cancer pipeline with a drug from Hanmi Pharmaceutical Co. Ltd. as part of a deal that could, in the end, be worth as much as $730 million to the South Korean firm.
HONG KONG – A proposed annual adjustment on the pricing of pharmaceuticals and medical devices in Japan backfired after manufacturers publicly opposed it. A multicountry coalition of organizations said the changes would inhibit growth and investment in the entire health care sector, impede innovation and adversely impact access by patients.
HONG KONG – A proposed annual adjustment on the pricing of pharmaceuticals and medical devices in Japan backfired after manufacturers publicly opposed it. A multi-country coalition of organizations said the changes would inhibit growth and investment in the entire health care sector, impede innovation and adversely impact access by patients.
HONG KONG — Chinese medical device maker, Mindray Medical (Shenzhen) will acquire for $72.6 million the remaining 49% stake in Dragonbio Surgical Implant (Wuhan, China) that it did not acquire in an earlier deal.
